Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth

Company Overview - Qiagen (QGEN) is expected to report a year-over-year increase in earnings, with a projected EPS of $0.60, reflecting a +9.1$520.73 million, up 2.3% from the previous year [3][10] - The earnings report is scheduled for February 5, 2025, and the actual results will significantly influence the stock price depending on whether they meet or exceed expectations [2][3] Earnings Estimates and Predictions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4] - The Most Accurate Estimate for Qiagen is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +2.76%, suggesting a bullish outlook from analysts [10][11] - Historical performance shows that Qiagen has beaten consensus EPS estimates three out of the last four quarters, with a recent surprise of +5.56% [12][13] Industry Context - In the broader context of the Zacks Medical - Biomedical and Genetics industry, Amgen (AMGN) is also expected to report positive results, with an EPS of $5.01, indicating a +6.4$8.84 billion, up 7.9% [17] - Amgen's consensus EPS estimate has been revised slightly lower, but a higher Most Accurate Estimate has resulted in an Earnings ESP of +3.15%, suggesting a likely earnings beat [18]